EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

by Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, Sylvia Lehmann, Gerhard Ehninger, Daniela E Aust, Jan Stoehlmacher-Williams
Published 2013-01-01

Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer

by Peter P. Grimminger, Jan Stöhlmacher, Daniel Vallböhmer, Paul M. Schneider, Arnulf H. Hölscher, Ralf Metzger, Peter V. Danenberg, Jan Brabender
Published 2009-01-01

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

by Andreas-Claudius Hoffmann, Peter Wild, Christina Leicht, Simone Bertz, Kathleen D. Danenberg, Peter V. Danenberg, Robert Stöhr, Michael Stöckle, Jan Lehmann, Martin Schuler, Arndt Hartmann
Published 2010-08-01

High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF

by Andreas-Claudius Hoffmann, Ryutaro Mori, Daniel Vallbohmer, Jan Brabender, Ellen Klein, Uta Drebber, Stephan E. Baldus, Janine Cooc, Mizutomo Azuma, Ralf Metzger, Arnulf H. Hoelscher, Kathleen D. Danenberg, Klaus L Prenzel, Peter V. Danenberg
Published 2008-07-01